Expensive Insulins, Pen Devices Dominate Diabetes Care in US

Analog insulins continue to represent more than 80% of prescriptions for type 2 diabetes in the US, despite rising costs and public scrutiny of pricing. Use of pen devices for delivery rose, too.

Related Keywords

Johns Hopkins University ,Maryland ,United States ,Baltimore ,American ,Ritar Kalyani , ,Health National Disease ,Drug Administration ,Division Of Endocrinology ,American Diabetes Association ,Metabolic Drugs Advisory Committee ,Blood Institute ,National Heart ,Medscape Medical ,Johns Hopkins University School ,While Biosimilar Use ,Therapeutic Index ,Pen Devices Also ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Diabetes Mellitus ,Insulin Therapy ,Insulin Analog ,Insulin Analogue ,Drug Costs ,Endocrinology ,Ndocrine System ,Biosimilars ,Biosimilar Drugs ,Follow On Biologics ,